Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas

Neuro Oncol. 2016 May;18(5):752-3. doi: 10.1093/neuonc/now013. Epub 2016 Feb 21.

¹ Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, California (C.N.K., S.M.); Clinical Cancer Genomics Laboratory, University of California, San Francisco, California (N.M.J., J.P.G., J.v.Z., I.Y., B.C.B.); Departments of Neurology and Neurosurgery, University of California, San Francisco, California (S.M.); Division of Neuropathology, Department of Pathology, University of California, San Francisco, California (D.A.S.).

No abstract available

Keywords: ACVR1; MUTYH; Turcot syndrome; familial adenomatous polyposis syndrome type 2; glioma; medulloblastoma; tumor predisposition syndrome.

Publication types